logo et courbe des catégory quantel medical
Ophthalmology

VITRA 2 receives approval from the FDA

VITRA 2 receives approval from the FDA

Quantel Medical announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for the Vitra 2® photocoagulator.

Vitra 2® includes all the key elements that have made the success of the Vitra photocoagulator such as reliability, compactness and versatility. It also features a wide a range of improvements and new functionalities:

Technology:
Vitra 2® features a new generation of optimized laser cavity with an increased max power level. It is also now compatible with SingleSpot and MultiSpot technologies.

All-new clinically oriented software:
Vitra 2® features an easy to use clinically oriented software interface simplifying the treatment procedures and the doctors’ workflow thanks to printable treatment reports.

Wide range of delivery systems:
Vitra 2® is compatible with Haag Streit and Zeiss types slit lamps, with Quantel Medical YAG and YAG/SLT lasers and can be connected to a wide range of delivery systems (operating Microscopes, laser indirect ophthalmoscopes and laser probes).

“After a successful career spanning more than 13 years and with more than 3000 units sold worldwide, Quantel Medical is proud to announce the renewal of its 532nm flagship Vitra photocoagulator” said Jean-Marc Gendre, CEO Quantel Medical. “We are very excited to bring our new 532nm laser to ophthalmologists and their patients. Thanks to its flexibility and its ease of use, we are sure that more and more surgeons will embrace the MultiSpot technology delivery mode and its associated treatments benefits for retinal photocoagulation.”

Already launched in Europe in 2018, the Vitra 2® laser has already met its market across the various countries where it is commercialized.

Logo quantel medical lumibird

Since 1993, Quantel Medical develops, manufactures and markets innovative medical laser and ultrasound solutions.

World leader in ophthalmology, its lasers and ultrasounds are designed to diagnose and treat the four main causes of blindness: cataracts, glaucoma, diabetic retinopathy and macular degeneration; and also dry eye disease.

Quantel Medical offers a range of Point of Care ultrasound, perfectly designed to meet the latest imaging needs in general medicine, musculoskeletal medicine, emergency medicine and anaesthesia/resuscitation, among others.

quantel medical all around the world

Map quantel medical international

Patients

Since 1993, Quantel Medical has been involved in developing, manufacturing and marketing medical equipment to provide health professionals with state-of-the-art diagnostic and therapeutic systems.

Visit our Patient information pages to learn more about the pathologies where our laser and ultrasound technologies are used to offer better standard of care.